Do you know what exactly is special about Levitra? It is Vardenafil hydrochloride, a strong molecule with a weight of 488.604 g/mol. As a PDE5 inhibitor, Vardenafil is closely related in both function and marketing to Sildenafil and Tadalafil though; it has a comparatively short effective time with less instances of failure. Those who have Levitra experience, have pointed out that unlike other ED pills, Levitra has worked for them on the very first attempt.
Let’s find out the actual selling points of the ED drug Levitra over its competitors.
The main ingredient of Levitra, Vardenafil hydrochloride is a potent molecule which requires smaller dosage to get into full action. The scientists refer to the molecule as far more stronger than Sildenafil and Tadalafil.
Levitra works wonders for men who had unsatisfactory or failed experience with Viagra. This statement has been confirmed time and again by the result of different research studies.
Vardenafil hydrochloride in Levitra is a boon to the diabetes patients, who are at a greater risk of erectile dysfunction due to uncontrolled sugar in blood that impedes the blood flow to the penis. Levitra has proved to be effective even in tight situations like high blood pressure as well as diabetes type2 when other ED drugs have failed to work.
Levitra’s highest dose of 20 mg is equal to 100 mg maximum dose of Viagra. Now, check out the lowest dose for Viagra, 12.5 mg and compare it to 2.5 mg pill of Levitra, its lowest dose levitra generique avis.
Those, who have been hit below the belt, are found to experience fewer side effects compared to other available PDE5 inhibitors. The mild and most common side effects are headaches, nasal congestion, flushing. What is more, with Levitra, you need not worry about your eyes as it has no detrimental side effects on vision. There is another add-on benefit with Levitra; it is less sensitive to food and alcohol, again, giving you ample chance for a romantic dinner with your ladylove while getting ready for the right moment.
The ED Market
Each of the PDE5 inhibitors will have it’s share in the erectile dysfunction market. It seems that Levitra has a promising future ahead, because, Vardenafil hydrochloride is strong enough to give an erection to the diabetics, who are the most easy victims of impotence, therefore considered as a substantial chunk of ED market.
The ever increasing market of erectile dysfunction is experiencing a head-on competition within the trio. For me, the ED market scenario is quite clear! Viagra, Levitra & Cialis, all of them have something special to offer. If Viagra has the longest track record, Cialis has 36 hours of action to offer, while Levitra has come up with effectiveness and gives strong erection to diabetics even with smaller doses.
The ED market giant remains Viagra though, owing to its consistency in performance but Levitra wins in rigid situations like diabetes.
Based on its advantages, Levitra has captured 50% of prescriptions for newly diagnosed erectile dysfunction patients. The MarketWatch report makes it almost clear as water, in spite of Viagra’s strong hold on the market, Bayer recorded a 16% advance in sales of its erectile dysfunction drug, to 73 million euros this year. The figures clearly show that Levitra will not wait for long to defeat its competitors.